Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cysteamine Hydrochloride
Therapeutic Area : Genetic Disease
Study Phase : Approved
Sponsor : AllianceRx Walgreens
Deal Size : Undisclosed
Deal Type : Partnership
Details : As an exclusive partner, AllianceRx Walgreens Prime is able to offer end-to-end solutions for Leadiant Biosciences and Cystaran patients. Cystaran, a topical ophthalmic therapy for the treatment of corneal cystine crystals in patients with cystinosis.
Brand Name : Cystaran
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 22, 2022
Lead Product(s) : Cysteamine Hydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Sponsor : AllianceRx Walgreens
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?